Hyperion Capital Advisors LP Decreases Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Hyperion Capital Advisors LP reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.0% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 25,627 shares of the healthcare conglomerate’s stock after selling 781 shares during the quarter. UnitedHealth Group accounts for about 7.0% of Hyperion Capital Advisors LP’s investment portfolio, making the stock its 5th largest position. Hyperion Capital Advisors LP’s holdings in UnitedHealth Group were worth $14,984,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the business. Elite Wealth Management Inc. boosted its holdings in shares of UnitedHealth Group by 13.7% in the 3rd quarter. Elite Wealth Management Inc. now owns 956 shares of the healthcare conglomerate’s stock worth $559,000 after purchasing an additional 115 shares in the last quarter. Public Sector Pension Investment Board boosted its holdings in shares of UnitedHealth Group by 11.9% in the 3rd quarter. Public Sector Pension Investment Board now owns 488,887 shares of the healthcare conglomerate’s stock worth $285,842,000 after purchasing an additional 52,140 shares in the last quarter. Fiduciary Trust Co boosted its holdings in shares of UnitedHealth Group by 0.7% in the 3rd quarter. Fiduciary Trust Co now owns 69,090 shares of the healthcare conglomerate’s stock worth $40,396,000 after purchasing an additional 496 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of UnitedHealth Group by 7.8% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 625,411 shares of the healthcare conglomerate’s stock worth $365,665,000 after purchasing an additional 45,195 shares in the last quarter. Finally, Bell Investment Advisors Inc grew its position in UnitedHealth Group by 6.1% during the 3rd quarter. Bell Investment Advisors Inc now owns 485 shares of the healthcare conglomerate’s stock worth $284,000 after acquiring an additional 28 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several analysts have commented on UNH shares. Cantor Fitzgerald raised their price objective on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. HSBC lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Stephens dropped their target price on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, November 20th. Finally, KeyCorp started coverage on UnitedHealth Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price target on the stock. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $618.26.

UnitedHealth Group Trading Up 0.3 %

UNH stock opened at $608.38 on Thursday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The company has a market capitalization of $559.88 billion, a price-to-earnings ratio of 39.63, a PEG ratio of 1.78 and a beta of 0.58. The business has a 50 day simple moving average of $584.09 and a two-hundred day simple moving average of $555.02.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period in the prior year, the company posted $6.56 EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.38%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.